In February the blog Vaccine Nation named Dr. Offit one of the 50 most influential people in vaccines, and just recently he was awarded the 2013 Maxwell Finland Award for Scientific Achievement, given annually by the National Foundation for Infectious Diseases (NFID).
Monthly Archive: March 2013
According to new research from The Children’s Hospital of Philadelphia and the University of Pennsylvania, two children with an aggressive form of childhood leukemia achieved a complete response after being treated with an innovative cell therapy.
A team of clinician-researchers from The Children’s Hospital of Philadelphia has created and validated the first set of standardized vital sign curves for heart rates and respiratory rates in hospitalized children.
Children who are later diagnosed with an autism spectrum disorder have subtle but measurable differences in attention as early as 7 months of age, a new study shows. Infants who went on to be diagnosed with autism are slower to shift their gaze from one object to another, according to the researchers, who identified specific brain circuits that seem to cause the slower response.
CHOP’s Peter Adamson, MD, who heads the Children’s Oncology Group, the largest organization in the world dedicated to childhood and adolescent cancer research, was recently interviewed by journalist Paul Goldberg for the March 15 issue of The Cancer Letter.
New on the Center for Injury Research and Prevention’s (CIRP) blog Research in Action are two stories that touch on a tragic topic: children and teenagers being injured in car crashes.
On Tuesday, U.S. News & World Report released its 2014 Best Graduate Schools rankings, and Children’s Hospital, along with its academic affiliate, the University of Pennsylvania’s Perelman School of Medicine, garnered the #1 spot in Pediatrics.
In a recent interview with the National Initiative for Children’s Healthcare Quality (NICHQ), Kwaku Ohene-Frempong, MD, Doctor Emeritus of CHOP’s Comprehensive Sickle Cell Center, discussed his work with sickle cell disease.
The innovative work being done by CHOP’s Stephen Grupp, MD, was recently featured on the CBS show The Doctors. Dr. Grupp, the Center for Childhood Cancer Research’s director of translational research, discussed his trial using immune therapy to treat an aggressive form of childhood leukemia, acute lymphoblastic leukemia (ALL).